Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: Implications for a biomarker of hepatocellular carcinoma

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Comunale, Mary Ann ^a   Rodemich Betesh, Lucy ^a   Hafner, Julie ^a   Wang, Mengjun ^a   Norton, Pamela ^a   di Bisceglie, Adrian M ^b   Block, Timothy ^a   Mehta, Anand ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; LECTIN; TUMOR MARKER; BIOLOGICAL MARKER; FUCOSE; ISOPROTEIN; LECTIN, ALEURIA AURANTIA; SERPINA1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; FUCOSYLATION; HEPATITIS B; HEPATITIS C; HUMAN; LINKAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; SENSITIVITY AND SPECIFICITY; CASE CONTROL STUDY; CHEMISTRY; COHORT ANALYSIS; DISEASE COURSE; GLYCOSYLATION; LABORATORY DIAGNOSIS; LIVER TUMOR; METABOLISM; PATHOLOGY;

ALEURIA AURANTIA; HEPATITIS C VIRUS;

ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; FALSE POSITIVE REACTIONS; FUCOSE; GLYCOSYLATION; HUMANS; LECTINS; LIVER CIRRHOSIS; LIVER NEOPLASMS; PROTEIN ISOFORMS; SENSITIVITY AND SPECIFICITY;

EID: 77957887133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012419     Document Type: Article

References (29)

1. Di Bisceglie AM (1989) Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection. Med Clin North Am 73: 985-997.
2. Block TM, Mehta AS, Fimmel CJ, Jordan R (2003) Molecular viral oncology of hepatocellular carcinoma. Oncogene 22: 5093-5107.
3. Marrero JA (2006) Hepatocellular carcinoma. Curr Opin Gastroenterol 22: 248-253.
4. Sallie R, Di Bisceglie AM (1994) Viral hepatitis and hepatocellular carcinoma. Gastroenterol Clin North Am 23: 567-579.
5. Lok A, McMahon B (2001) Chronic hepatitis B. Hepatology 34: 1225-1241.
6. El Serag HB, Mason AC, Key C (2001) Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 33: 62-65.
7. Sarbah SA, Gramlich T, Younoszai A, Osmack P, Goormastic M, et al. (2004) Risk factors for hepatocellular carcinoma in patients with cirrhosis. Dig Dis Sci 49: 850-853.
8. Alpert ME, Uriel J, de Nechaud B (1968) alpha fetogloblin in the diagnosis of human hepatoma. N Engl J Med 278: 984-986.
9. Ruoslahti E, Salaspuro M, Pihko H, Andersson L, Seppala M (1974) Serum alpha-fetoprotein: diagnostic significance in liver disease. Br Med J 2: 527-529.
10. Di Bisceglie AM, Hoofnagle JH (1989) Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer 64: 2117-2120.
11. Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, et al. (2005) GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 43: 1007-1012.
12. Sherman M (2005) Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 25: 143-154.
13. Rudd PM, Dwek RA (1997) Glycosylation: heterogeneity and the 3D structure of proteins. Crit Rev Biochem Mol Biol 32: 1-100.
14. Aoyagi Y, Suzuki Y, Igarashi K, Yokota T, Mori S, et al. (1993) Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor. Cancer 72: 615-618.
15. Naitoh A, Aoyagi Y, Asakura H (1999) Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 14: 436-445.
16. Aoyagi Y, Isokawa O, Suda T, Watanabe M, Suzuki Y, et al. (1998) The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Cancer 83: 2076-2082.
17. Noda K, Miyoshi E, Gu J, Gao CX, Nakahara S, et al. (2003) Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. Cancer Res 63: 6282-6289.
18. Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, et al. (2005) Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A 102: 779-784.
19. Comunale MA, Lowman M, Long RE, Krakover J, Philip R, Seeholzer S, Evans AA, Hann HWL, Block TM, Mehta AS (2006) Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. Journal of Proteome Research 6: 308-315.
20. Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, et al. (2008) Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med 359: 2429-2441.
21. Guile GR, Rudd PM, Wing DR, Prime SB, Dwek RA (1996) A rapid highresolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal Biochem 240: 210-226.
22. Jeppsson JO, Einarsson R (1992) Genetic variants of alpha 1-antitrypsin and hemoglobin typed by isoelectric focusing in preselected narrow pH gradients with PhastSystem. Clin Chem 38: 577-580.
23. Brooks KP, Iammarino RM (1985) Determination of alpha-1-antitrypsin phenotypes and M subtypes by isoelectric focusing in immobilized pH gradients. Clin Biochem 18: 280-284.
24. Kolarich D, Weber A, Turecek PL, Schwarz HP, Altmann F (2006) Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms. Proteomics 6: 3369-3380.
25. Liu XE, Desmyter L, Gao CF, Laroy W, Dewaele S, et al. (2007) N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 46: 1426-1435.
26. Nakagawa T, Uozumi N, Nakano M, Mizuno-Horikawa Y, Okuyama N, et al. (2006) Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts. J Biol Chem 281: 29797-29806.
27. Abd Hamid UM, Royle L, Saldova R, Radcliffe CM, Harvey DJ, et al. (2008) A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 18: 1105-1118.
28. Arnold JN, Saldova R, Hamid UM, Rudd PM (2008) Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8: 3284-3293.
29. Peracaula R, Sarrats A, Saldova R, Pla E, Fort E, et al. (2010) Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. PROTEOMICS - Clinical Applications In press.